The Journal of Allergy and Clinical Immunology
Volume 121, Issue 1 , Pages 81-87 , January 2008

An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease

  • Marcus Shaker, MD

      Affiliations

    • Section of Allergy and Clinical Immunology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • Center for the Evaluative Clinical Sciences, Hanover, NH
    • Corresponding Author InformationReprint requests: Marcus S. Shaker, MD, Department of Pediatrics and Community and Family Medicine, Section of Allergy and Clinical Immunology, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756.
    • ,
  • Ano Lobb, BA

      Affiliations

    • Center for the Evaluative Clinical Sciences, Hanover, NH
    • ,
  • Pamela Jenkins, MD, PhD

      Affiliations

    • Department of Pediatrics, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Daniel O'Rourke, MD

      Affiliations

    • Section of Cardiology, Department of Internal Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Steve K. Takemoto, PhD

      Affiliations

    • Saint Louis University Center for Outcomes Research, Saint Louis University School of Medicine, St Louis, Mo
    • ,
  • Salil Sheth, MHA

      Affiliations

    • Saint Louis University Center for Outcomes Research, Saint Louis University School of Medicine, St Louis, Mo
    • ,
  • Thomas Burroughs, PhD

      Affiliations

    • Saint Louis University Center for Outcomes Research, Saint Louis University School of Medicine, St Louis, Mo
    • ,
  • Mark S. Dykewicz, MD

      Affiliations

    • Section of Allergy and Clinical Immunology, Division of Immunobiology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Mo

Received 11 December 2006 ,Revised 22 June 2007 ,Accepted 26 June 2007.

References 

  1. Centers for Disease Control and Prevention. National Center for Environmental Health, Behavioral Risk Factor Surveillance System 2004 prevalence data. Available at: http://www.cdc.gov/asthma/brfss/04/brfssdata.htm#lc. Accessed March 8, 2007.
  2. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ. 2004;328:434
  3. McDonald JR, Mathison DA, Stevenson DD. Aspirin intolerance in asthma. Detection by oral challenge. J Allergy Clin Immunol. 1972;50:198–207
  4. Kasper L, Sladek K, Duplaga M, Bochenek G, Liebhart J, Gladysz U, et al. Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland. Allergy. 2003;58:1064–1066
  5. Mascia K, Haselkorn T, Deniz YM, Miller DP, Bleecker ER, Borish L. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2005;116:970–975
  6. Berges-Gimeno MP, Simon RA, Stevenson DD. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2003;90:338–341
  7. Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2003;111:180–186
  8. Gosepath J, Schafer D, Mann WJ. [Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day]. Laryngorhinootologie. 2002;81:732–738
  9. Gollapudi RR, Teirstein PS, Stevenson DD, Simon RA. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA. 2004;292:3017–3023
  10. Ramanuja S, Breall JA, Kalaria VG. Approach to “aspirin allergy” in cardiovascular patients. Circulation. 2004;110:e1–e4
  11. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86
  12. Schaefer OP, Gore JM. Aspirin sensitivity: the role for aspirin challenge and desensitization in postmyocardial infarction patients. Cardiology. 1999;91:8–13
  13. Silberman S, Neukirch-Stoop C, Steg PG. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting. Am J Cardiol. 2005;95:509–510
  14. Gaspoz JM, Coxson PG, Goldman PA, Williams LW, Kuntz KM, Hunink MG, et al. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med. 2002;346:1800–1806
  15. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329–1339
  16. Hunink MG. Decision making in health and medicine: integrating evidence and values. Cambridge (United Kingdom): Cambridge University Press; 2004;
  17. Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002;22:417–430
  18. Drugstore.com online pharmacy. Available at: http://www.drugstore.com/. Accessed March 6, 2006.
  19. Murphy MP, Fishman P, Short SO, Sullivan SD, Yueh B, Weymuller EA. Health care utilization and cost among adults with chronic rhinosinusitis enrolled in a health maintenance organization. Otolaryngol Head Neck Surg. 2002;127:367–376
  20. Ray NF, Baraniuk JN, Thamer M, Rinehart CS, Gergen PJ, Kaliner M, et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol. 1999;103:408–414
  21. Ray NF, Baraniuk JN, Thamer M, Rinehart CS, Gergen PJ, Kaliner M, et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses. J Allergy Clin Immunol. 1999;103:401–407
  22. HCUPnet, Healthcare Cost and Utilization Project. Rockville (MD): Agency for Healthcare Research and Quality. Available at: http://www.ahrq.gov/HCUPnet/. Accessed June 6, 2005.
  23. Bureau of Labor Statistics. Available at: http://www.bls.gov/. Accessed March 10, 2006.
  24. National Center for Health Statistics Life Tables. Available at: http://www.cdc.gov/nchs/products/pubs/pubd/lftbls/life/1966.htm. Accessed March 6, 2006.
  25. Spector S, Bernstein I, Li J, Berger W, Kaliner M, Schuller D, et al. Parameters for the diagnosis and management of sinusitis. J Allergy Clin Immunol. 1998;102(suppl):S107–S144
  26. Boudreaux ED, Emond SD, Clark S, Camargo CA. Acute asthma among adults presenting to the emergency department: the role of race/ethnicity and socioeconomic status. Chest. 2003;124:803–812
  27. Wong JT, Nagy CS, Krinzman SJ, Maclean JA, Bloch KJ. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema. J Allergy Clin Immunol. 2000;105:997–1001
  28. Yuval R, Halon D, Lewis B. Perceived disability and lifestyle modification following hospitalization for non-ST elevation versus ST elevation acute coronary syndromes: the patients' point of view. Eur J Cardiovasc Nurs. 2007;
  29. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293–1304
  30. Blumenschein K, Johannesson M. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol. 1998;80:189–194
  31. Mittmann N, Trakas K, Risebrough N, Liu BA. Utility scores for chronic conditions in a community-dwelling population. Pharmacoeconomics. 1999;15:369–376
  32. Bradley CJ, Kroll J, Holmes-Rovner M. The health and activities limitation index in patients with acute myocardial infarction. J Clin Epidemiol. 2000;53:555–562
  33. Zillich AJ, Blumenschein K, Johannesson M, Freeman P. Assessment of the relationship between measures of disease severity, quality of life, and willingness to pay in asthma. Pharmacoeconomics. 2002;20:257–265
  34. White AA, Stevenson DD, Simon RA. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2005;95:330–335
  35. Stevenson DD, Simon RA. Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol. 2006;118:801–804
  36. Settipane RA, Stevenson DD. Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol. 1989;84:26–33
  37. Jenkins C. Recommending analgesics for people with asthma. Am J Ther. 2000;7:55–61
  38. Tan K, Sulke N, Taub N, Sowton E. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience. J Am Coll Cardiol. 1995;25:855–865
  39. Popma JJ, Berger P, Ohman EM, Harrington RA, Grines C, Weitz JI. Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(suppl):576S–599S
  40. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998;339:1665–1671
  41. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502
  42. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331–337

 Disclosure of potential conflict of interest: S. K. Takemoto has consulting arrangements with, has received grant support from, and is on the speakers' bureau for Novartis and Astellas. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(07)01386-3

doi: 10.1016/j.jaci.2007.06.047

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 1 , Pages 81-87 , January 2008

Article Tools

* Image Usage & Resolution